|
市場調查報告書
全球乳房活組織檢驗裝置市場
Breast Biopsy Devices
|
全球乳房活組織檢驗裝置市場 是由出版商Global Industry Analysts, Inc.在2010年02月所出版的。
這份英文市場調查報告書包含Pages: 220 價格從美金3450起跳。
本報告書對全球乳房活組織檢驗裝置市場進行分析，包含乳癌的診斷與治療、乳房活組織檢驗與乳房活組織檢驗裝置之概要、以歐洲為中心的世界各地區動向、競爭動向整理等內容，概述如下。
第1章 導論・調査方法・產品定義
第2章 歐洲的市場報告
- 業界概要
- 序文
- 市場機會
- 乳癌：歐洲女性的一般惡性腫瘤
- 歐洲活組織檢驗裝置
- 廣泛導入最新診斷裝置因乳房活組織檢驗裝置的需求而擴大
- 主要統計數據
- 競爭過程
- 現在的市場動向
- 市場動向與課題
- 價格要因
- 乳癌治療的技術革新
- 各地區市場觀察
- 產品概要
- 乳癌
- 乳癌篩檢
- 乳癌診斷
- 乳房活組織檢驗
- 乳房活組織檢驗處置
- 一般所用的乳房活組織檢驗裝置
- 乳房圖像技術的進歩
- 活組織檢驗組織標記
- 產品革新／導入
- 近年的業界活動
- 主要企業
- 全球市場觀察
第3章 競爭環境
Abstract
This report analyzes the European market for Breast Biopsy Devices in US$
Million. Annual Forecasts are provided for the period 2007 through 2015. Also,
a six-year historic analysis is provided for the market. The report profiles
25 companies including many key and niche players such as C. R. Bard Inc.,
Bard Biopsy Systems, Cardinal Health, Inc., Ethicon Endo-Surgery, Inc., GE
Healthcare, Hologic, Inc., iCAD, Inc., Intact Medical Corporation, Koninklijke
Philips Electronics N.V., Rubicor Medical, Inc., Sanarus Technologies, SenoRx,
Inc., and Siemens AG. Market data and analytics are derived from primary and
secondary research. Company profiles are mostly extracted from URL research
and reported select online sources.
Table of Contents
I. INTRODUCTION, METHODOLOGY & PRODUCT DEFINITIONS
- Study Reliability and Reporting Limitations
- Disclaimers
- Data Interpretation & Reporting Level
- Quantitative Techniques & Analytics
- Product Definitions and Scope of Study
II. A EUROPEAN MARKET REPORT
1. INDUSTRY OVERVIEW
- A Prelude
- Market Opportunity
- Breast Cancer: A Common Malignancy Among Females in the Western World
- Increased Instances of Breast Cancer in Younger Women!
- European Biopsy Devices Market
- Widespread Adoption of Advanced Diagnostic Systems Will Increase Demand
for Breast Biopsy Devices
- Key Statistics:
- Table 1: Worldwide Breast Cancer Incidence Rates & Mortality Rate (Per
100,000 persons) for the year 2007 (includes corresponding Graph/Chart)
- Table 2: Percentage of Five-Year Survival Rate For Breast Cancer by Cancer
Stage (includes corresponding Graph/Chart)
- Competitive Scenario:
- Current Market Conditions
- Impact of Recession
- Key Market Trends & Issues: A Review
- Continuous Fight Against Cancer: A Key Propeller for Growth
- Population Aging Makes Rise Of Cancer Diagnostics Inevitable
- Table 3: Probability of Developing Breast Cancer by Age Group
- Table 4: Probability of Surviving Breast Cancer by Age Group (includes
corresponding Graph/Chart)
- Table 5: Population Over 65 Years and Above in North America, Western
Europe and Eastern Europe for the year 2007 (In Millions) (includes
corresponding Graph/Chart)
- Promising Developments in Breast Cancer Diagnosis Underway
- Needle Biopsy Score Over Open Biopsy
- Widespread Awareness Among Patients & Practitioners: The Need of the
Hour
- Rise in Use of Breast Markers
- Rise in Use of MRI Guided Breast Biopsy
- Government Breast Cancer Screening Programs Drive Biopsy Devices Market
- Rise in Use of Single Insertion Breast Biopsy Needle
- Roll Out of Integrated Breast Centers
- Vacuum-Assisted Biopsy Gain Physician Preference
- Table 6: Reimbursement Benefits for Vacuum-Assisted Over Core Needle
Biopsy in Office Based Setting in the US Market for the year 2007
- Reimbursement & Price Sensitivity: Key Challenges for Breast Biopsy
Market
- Susceptibility to Radiation Exposure May Hinder Growth
- Competing Solutions May Limit Need of Breast Biopsy Procedures
- High Costs of Biopsy Markers May Constrain Growth
- Pricing Factors
- Technology Innovations in Breast Care Management:
- Breast Thermography - An Alternative to Mammography
- Advanced MRI Technique May Limit Breast Biopsies in Women
- Identification of New Genes May Improve Breast Cancer Diagnosis
- Innovative MRI Technique Identifies Cancerous Breast Tumors
2. REGIONAL PERSPECTIVE
- Europe
- Market Overview
- Changing Physician Preferences Shape Breast Biopsy Market
- Market Restraints
- Key Statistics:
- Table 7: Top Three Cancers Among Europeans for the year 2006 (includes
corresponding Graph/Chart)
- Table 8: European Age-Standardised Rate (ASR) for Breast Cancer Incidence
per 100, 000 Individuals, By Country, for the year 2006 (includes
corresponding Graph/Chart)
- Table 9: European Age-Standardised Rate (ASR) for Breast Cancer Mortality
per 100, 000 Individuals, By Country, for the year 2006 (includes
corresponding Graph/Chart)
- Germany
- Italy
- Table 10: Female Breast Cancer Cases in Italy (2005): Breakdown of
Mortality, Incidence and Prevalence by Number of Cases for Key Italian Regions
(includes corresponding Graph/Chart)
- United Kingdom
- Role of Government
- Key Statistics:
- Table 11: Percentage Share Breakdown of Common Causes of Female Cancer
Deaths in the UK for the year 2007 (includes corresponding Graph/Chart)
- Table 12: Breakdown of New Breast Cancer Cases Diagnosed in the UK by
Gender for the year 2006 (includes corresponding Graph/Chart)
- Table 13: Breakdown of Breast Cancer Mortality in the UK by Gender for the
year 2007 (includes corresponding Graph/Chart)
- Other Western Nations: Facts & Figures
- United States
- Key Statistics:
- Table 14: Breast Cancer in the United States: Breakdown of Incidence Rate
By Ethnic Group for the year 2007
- Table 15: Breast Cancer in the United States: Breakdown of Mortality Rate
By Ethnic Group for the year 2007
- Table 16: Breakdown of Number of Breast Biopsy Procedures in the United
States for the Years 2008 & 2013 (Number of Procedures in 000s) (includes
corresponding Graph/Chart)
- Table 17: US Breast Biopsy Devices Market (2008): Percentage Share
Breakdown of Revenues by Key Players (includes corresponding Graph/Chart)
- Table 18: US Vaccuum-Assisted Breast Biopsy Disposables Market (2007):
Percentage Share Breakdown of Revenues by Key Players (includes corresponding
Graph/Chart)
- Table 19: US Vaccuum-Assisted Biopsy Procedures (2007): Percentage Share
Breakdown by Procedures Type (includes corresponding Graph/Chart)
- Table 20: US Biopsy Products Market (2008): Percentage Share Breakdown of
Revenues by Product Segment (includes corresponding Graph/Chart)
- Canada
- Table 21: New Breast Cancer-Related Diagnosis in Canada (2007): Percentage
Share Breakdown of Female Breast Cancer Incidence by Age Group (includes
corresponding Graph/Chart)
- Table 22: Breast Cancer-Related Deaths in Canada (2007): Percentage Share
Breakdown of Female Breast Cancer Related Death by Age Group (includes
corresponding Graph/Chart)
3. PRODUCT OVERVIEW
- Breast Cancer
- Risk Factors
- Breast Cancer Screening
- Breast Cancer Diagnosis
- Breast Biopsy
- Breast Biopsy Procedures
- Surgical Biopsy
- Needle Biopsy
- Fine Needle Aspiration
- Core Needle Biopsy
- Vacuum-Assisted Biopsy
- Commonly Used Breast Biopsy Devices
- Spring Loaded Biopsy Needle
- Vacuum-Assisted Core Biopsy Device
- Minimally Invasive Breast Biopsy (MIBB) Device
- Advanced Breast Biopsy Instrumentation (ABBI) Device
- Mammotome
- Advances in Breast Imaging Techniques
- Ultrasound Image Guidance
- Stereotactic Image Guidance
- Magnetic Resonance Imaging
- Mammotome(r) Breast Biopsy System
- Digital Spot-View Mammography Enhances Breast Biopsy
- Biopsy Tissue Markers
4. PRODUCT INNOVATIONS/INTRODUCTIONS
- Senorx Unveils New Model of Senosonix System
- SenoRx to Release StarchMark(tm)
- SenoRx Unveils EnCor(r)
- Siemens Healthcare Launches New Biopsy Device
5. RECENT INDUSTRY ACTIVITY
- Terason Enters into Agreement with SenoRx
- SenoRx Receives CE Mark Rights for Contura(tm) MLB
- RevMed Inks a Global License with SPD
- Sanarus Technologies Acquires Sanarus Medical
- Hologic Obtains CE Mark Approval for Celero(r)
- Echoserve, SenoRx Enter Into Co-Promotion Deal
- Naviscan Receives FDA' s Approval for Stereo Navigator(tm)
- Volcano Acquires Novelis
- SenoRx Receives CE Mark Approval for SenoSonix
- Hologic Completes Merger with Cytyc Corporation
6. FOCUS ON SELECT PLAYERS
- C. R. Bard Inc. (USA)
- Bard Biopsy Systems (USA)
- Cardinal Health, Inc. (USA)
- Ethicon Endo-Surgery, Inc (USA)
- GE Healthcare (UK)
- Hologic, Inc. (USA)
- iCAD, Inc. (USA)
- Intact Medical Corporation (USA)
- Koninklijke Philips Electronics N.V. (The Netherlands)
- Rubicor Medical, Inc., (USA)
- Sanarus Technologies, LLC (USA)
- SenoRx, Inc (USA)
- Siemens AG (Germany)
7. GLOBAL MARKET PERSPECTIVE
- Table 23: European Recent Past, Current & Future Analysis for Breast
Biopsy Devices with Annual Sales Figures in US$ Million for Years 2007 through
2015 (includes corresponding Graph/Chart)
- Table 24: European Historic Review for Breast Biopsy Devices with Annual
Sales Figures in US$ Million for Years 2001 through 2006 (includes
corresponding Graph/Chart)
III. COMPETITIVE LANDSCAPE
|
